chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fever for 115 hours (nearly five days) between 100.2 and 102.8, despite taking round the clock, and beyond the maximum doses, of Tylenol and Motrin moderate to severe headache for 115 hours (nearly five days), despite taking round the clock, and beyond the maximum doses, of Tylenol and Motrin loss of appetite for five days fatigue for five days
Heart is not working right. Fast heartbeat, short of breath, bloating, co appetite. Checked in hospital. Still under treatment in hospital
Acute hypotension secondary to nitroglycerin participant felt he was experience a form of angina.
Red circle appeared on my arm. It was red, warm to touch, hurt to touch, itchy and raised.
During injection, felt burning sensation as vacine traveled through upper left arm. Few hours later, upper left arm very painful to touch & cannot be moved without intense pain. Next day, upper left arm not so sensitive to touch but not able to move or lift left arm without intense pain. Felt like muscle in upper left arm was weakened, cannot sustain left arm weight or move left arm without intense pain. Went back to doctor's office. PA-C prescribed methylprednisolone, 4 mg, (MEDROL DOSEPACK). Took 6 tablets at 2pm. Later used pulleys to force left arm to move. Pain still intense. Next day, pain not so intense & had some range of motion. Arm improved but little range of motion. Heat has helped.
About 6 hours after the shot I had fever, chills and a headache. About 24 hours after I had: Face swelling, Shortness of breath, Difficulty breathing, Tongue swelling., Throat swelling,  Extreme fatigue, Fever, Chills, Headache, shaking, heart palpitations and Muscle weakness. The doctor prescribed antihistamine, albuterol inhaler, Tylenol, steroids. After a week of treatment there was no change. I went back to the doctor with the same symptoms. Doctor gave more of the same medications. After another week of medication the swelling shortness of breath and difficulty breathing have gotten better, but are not gone. I still have fatigue and muscle weakness chest tightness and a swollen face after 22 days.
patient received pfizer monovalent vaccine as booster dose instead of bivalent. She is not experiencing any side effects or symptoms at this time.
Mom called our office on 5/24/2023 and states that she took child to the doctor that day because she had developed a full body rash and is sleeping more. Physician ruled it as a reaction to the MMR vaccine received on 5/5/2023. Nothing prescibed.
Dermatitis of scalp; Alopecia; Patient's head stared itching; Patient's head stared flaking; This spontaneous case was reported by a consumer and describes the occurrence of DERMATITIS (Dermatitis of scalp), PRURITUS (Patient's head stared itching), SKIN EXFOLIATION (Patient's head stared flaking) and ALOPECIA (Alopecia) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027L20A and 028L20A) for COVID-19 vaccination.     Concurrent medical conditions included CIDP. Concomitant products included AZATHIOPRINE (IMURAN [AZATHIOPRINE]) and TRIAMCINOLONE ACETONIDE (KENALOG 40) for CIDP.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Jan-2021, the patient experienced PRURITUS (Patient's head stared itching) and SKIN EXFOLIATION (Patient's head stared flaking). On 27-Jan-2021, the patient experienced ALOPECIA (Alopecia). On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced DERMATITIS (Dermatitis of scalp). The patient was treated with CLOBETASOL for Itching, at a dose of 1 dosage form. At the time of the report, DERMATITIS (Dermatitis of scalp) had not resolved and PRURITUS (Patient's head stared itching), SKIN EXFOLIATION (Patient's head stared flaking) and ALOPECIA (Alopecia) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       On 18 Jun 2021, the patient's hair started to fall out. On 27 Jun 2021, the patient was diagnosed with Alopecia.   This case was linked to MOD-2021-229351 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 01-Jul-2021: Updated reporter's address, patient's age, DOB, medical history, concomitant medications, batch/lot number, start date of the suspect product,treatment medications and new events were added.
Exposure to AREXVY during pregnancy; 36 years old patient received Arexvy vaccine; This non-serious prospective pregnancy case was reported by a physician via call center representative and described the occurrence of vaccine exposure during pregnancy in a 36-year-old female patient who received RSVPreF3 adjuvanted (Arexvy) (batch number X723B, expiry date 08-DEC-2024) for prophylaxis.   On 29-SEP-2023, the patient received Arexvy (left arm). On 29-SEP-2023, an unknown time after receiving Arexvy, the patient experienced inappropriate age at vaccine administration (Verbatim: 36 years old patient received Arexvy vaccine). On an unknown date, the patient experienced vaccine exposure during pregnancy (Verbatim: Exposure to AREXVY during pregnancy). The outcome of the vaccine exposure during pregnancy and inappropriate age at vaccine administration were unknown.   Pregnancy exposure: Pregnancy Exposure (Arexvy): Trimester unknown Pregnancy Outcome: Pregnancy was ongoing   Additional Information: GSK Receipt Date: 13-Nov-2023 The reporter reported that the pregnant woman patient received Arexvy vaccine, which led to vaccine exposure during pregnancy. The patient received Arexvy who was younger than the indicated age which led to inappropriate age at vaccine administration. The reporter did consent to follow up.
The night of the vaccine I experienced trouble sleeping and could not go to sleep. The morning after I had a very bad headache and a rash on my right arm and shoulder where near proximity of where the shot was given. It was red dots, no itching, no discomfort. I felt feverish as the day proceeded but never had a temperature. The second day after the shot I had the headache the rash was 75% resolved.
First Dose - normal event : just felt a little tired. Second Dose: Day of shot: felt fine. Day 1: severe achiness, bad headache, weakness, tired, nausea. Day 2: bad headache, achiness, tired, nausea. Day 3: Bad headache. Day 4: Bad headache. Day 5 Normal headache. Day 6: headache gone. May 7th : got all the symptoms of COVID-19. May 10th : went to CVS to be tested for COVID-19.  It was negative. MAY 17TH ; Finally feeling better.
This spontaneous report as received from a pharmacy technician refers to a 5 year old patient of unknown gender. Patient's concurrent conditions, medical history, concomitant medications, drug reactions and allergies were not reported. On 02-FEB-2018, the patient was vaccinated with improperly stored dose of VARIVAX (lot # N022979, expiry 23-AUG-2019) for prophylaxis. No adverse effect was reported. The VARIVAX temperature excursion occurred on 14-DEC-2017 and 30-DEC-2017. On 14-DEC-2017, the vaccine was exposed to the temperature of 16.9 degree Fahrenheit (F) for 30 minutes. On 30-DEC-2017, the vaccine was exposed to the temperature of 6 degree Fahrenheit (F) to 14 degree F for 30 minutes. It was reported that the event was because of data logger. No product quality complaint was involved. This is one of the several reports received from the same reporter source. Sender's Comments: US-009507513-1802USA001558.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 24-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 09Apr2021 as dose 2, single (Lot number: FW0161) and on 20Nov2021 as dose 3 (booster), single (Lot number: FH8027) at the age of 24 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Crohn's disease" (unspecified if ongoing); "Essential tremor" (unspecified if ongoing); "known allergies: gadolinium" (unspecified if ongoing); "known allergies: gluten" (unspecified if ongoing); "known allergies: Puffer fish" (unspecified if ongoing). Concomitant medication(s) included: STELARA taken for crohn's disease, start date: 18Nov2021. Past drug history included: Amoxicillin, reaction(s): "allergies". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Paxlovid was given as treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19. The patient was given Paxlovid from 26Jul2022 to 31Jul2022 as COVID-19 treatment. No follow-up attempts are possible. No further information is expected.
pt recvd vax; 8 days later exp itching arm & 8 bumps; (erythematous papules) 2 1/2-2cm below inject site;pt was tx w/ dph & all sxs resolved p/ 2 wks;
Shingles outbreak; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles outbreak) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025A21A and 030M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (Shingles outbreak). At the time of the report, HERPES ZOSTER (Shingles outbreak) had not resolved.            No relevant concomitant medications were provided. Patient was on 3 months worth of antiviral treatment. Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-014652 (Patient Link).
Had limb swelling, redness and pain in the limb where DTaP vaccine was administered
I have a large red circle approximately 8cm in diameter around the injection site and is still very red after 9 days.  It is slightly itchy but has no tenderness.
three doses of Shingrix; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of extra dose administered in a 76-year-old female patient who received Herpes zoster (Shingrix) (batch number PF222, expiry date 16-AUG-2025) for prophylaxis.   On 10-NOV-2023, the patient received the 3rd dose of Shingrix. On 10-NOV-2023, an unknown time after receiving Shingrix, the patient experienced extra dose administered (Verbatim: three doses of Shingrix). The outcome of the extra dose administered was unknown.   Additional Information: GSK Receipt Date:13-NOV-2023 The pharmacist contacted and inquired about Shingrix and what information was available about the safety data available about the safety of three doses of Shingrix. Partial information about patient, vaccine and event was given. The reporter consented to follow up. The Vaccine Administration Facility was the same as Primary Reporter. The patient received 3rd dose of Shingrix, which led to extra dose administered.
ED Discharged  5/4/2021 (26 minutes)   Last attending ? Treatment team Viral illness Clinical impression Covid-19 Screening Chief complaint
(R) lower deltoid localized rxn to flu shot. TX with ice and ibuprofen.
Fever, fatigue, nausea, body aches, head ache, chills.
pt recv vax 4/1/98 & 4/25/98 pt exp runny nose & swollen left cheek (parotitis);pt recovered;
HEART PAIN AND LEFT ARM PAIN, DAY AFTER SHOT FOR 8 DAYS AND STILL OCCASIONAL.
I had severe pain/aches in the administered arm.  Aches were so sever that I was up all night in tears and unable to sleep.  I also had an awful ache at the base of my neck and was extremely tired the day after receiving the second shot.
Sx's started a few hours after injection. Pt states arm became very red and swelled up and became hard at the site of injection.
Shingles outbreak at 43 years old. This has been verified by a dermatologist. My immune system is no longer suppressing the chickenpox virus as it had before the vaccine.
Symtoms-the expected was the soreness at injection site, but at about 12 hours after the shot I experienced shivering at first was minimal and then it got to the point I could do not anything for 2 hours of massive shakes.  Then I got a slight fever, headaches, and general aches and pain.  I took aspirin which help me sleep.   The morning after, I was dizzy and weak.  I had a hard time walking around the house and I am normally an endurance runner.
This spontaneous report as received from a physician via field representative and refers to a female patient of unknown age. The patient's concurrent conditions, pertinent medical history, concomitant therapies, drug reactions or allergies were not reported. In approximately 2018 (alse reported as "within the last year"), the patient was vaccinated with GARDASIL 9, intramuscularly (dose, lot# and expiration date were not reported) for prophylaxis. The physician reported that a patient received a dose of GARDASIL 9 and developed dizziness afterwards. The outcome of dizziness was unknown. The relatedness between the event and GARDASIL 9 was not reported.
Began to limp; favor left leg several hours after shots given. Progressed to refusal to bear weight 3 days after shot was given. No fever, redness, warmth, swelling at site of vaccines. Normal exam and decreased range of motion at left leg hip/knee 2 inches to apparent pain.
Pt notified office today that after the Zostavax vaccine on 10/26/07 he experienced fast heart rate and weakness about 3 hrs.later lasting  several hours. States he went to be and was better in the morning.
3.5" x 2" area of erythema, swelling, tenderness and warm involving area of shot and extending distally. Began 24 hr after vaccine. Did start on cephalexin for possible infection. Rec'd heat compress, ibuprofen and BENADRYL.
Fever; chills; body aches; vomiting; diarrhea; This is a spontaneous report from a contactable nurse via Pfizer Sales Representative. This nurse reported same events for 3 patients. This is third of 3 reports. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced fever, chills, body aches, vomiting and diarrhea all on an unspecified date. Symptoms began almost immediately after receiving shot and lasted for about 12 hours. Event took place after use of product. The outcome of the events was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021072645 same reporter/drug/event, different patient;US-PFIZER INC-2021072646 same reporter/drug/event, different patient
PT C/O TINGLING AND SCRATCHY THROAT, AND ANXIETY/NERVOUSNESS. PT THEN STATED SHE WAS OK  TO GO HOME.  BP 171/64 HR 71 O2 99%  DR. ADVISED ( AFTER FURTHER MONITORING AND REPEAT VITALS, PT APPEARED STABLE; NOT IN ACUTE DISTRESS. PT INSTRUCTED TO TAKE PO BENADRYL ONCE SHE MADE IT HOME SINCE SHE WAS DRIVING ALONE.)
pt recvd vax & exp a swollen area @ the inject site; 1 month post vax exp 1 cm atrophied area @ inject site;
feels weak; left-sided headache; Extreme fatigue; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (left-sided headache), FATIGUE (Extreme fatigue) and ASTHENIA (feels weak) in a 22-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939676) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jul-2021, the patient experienced HEADACHE (left-sided headache), FATIGUE (Extreme fatigue) and ASTHENIA (feels weak). At the time of the report, HEADACHE (left-sided headache) had not resolved and FATIGUE (Extreme fatigue) and ASTHENIA (feels weak) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient was not taking any regular prescribed medications and had no known allergies. Patient had taken a pain reliever but still had the headache. Caller stated that they would see HCP next day.
Temporary Confusion; This spontaneous case was reported by a consumer and describes the occurrence of CONFUSIONAL STATE (Temporary Confusion) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced CONFUSIONAL STATE (Temporary Confusion). At the time of the report, CONFUSIONAL STATE (Temporary Confusion) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 75-year-old female patient who received Flu Seasonal QIV Dresden for prophylaxis. On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season at an unknown dose. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was recovered/resolved. It was unknown if the reporter considered the injection site pain to be related to Influenza vaccine Quadrivalent unspecified season. Additional details were provided as follows: The age at vaccination was not reported. After receiving flu vaccine, the patient experienced usual reactions included hurting at the injection site for a couple of days and then it would have resolved. This case has been linked with US2019032498, reported for same patient.
Information has been received from a registered nurse concerning a 22 year old nurse female employee with no known medical history on allergies, who received three doses of RECOMBIVAX HB. The patient "currently" has a negative hepatitis B titer. Unspecified medical attention was sought. Follow up information indicated the patient had negative antibodies. It is not known "which series she received". No additional information is expected.
Patient had 2 immunizations on 11/20/2013.. when she woke up 11-21-2-13 left arm hurt and during the night felt arm was painful, felt achy, feverish and left arm feels swollen and is red and warm 10 x 12 cm. Area on 11-22-13,  Pts temp 99.2. Pt to hot pocket or ice it whichever feels better and call us on 11-25-13 with update.
Severe chills, body aches, severe HA, moderate fevers, loss of appetite, localized muscle spasms, rash began about 12 hours after injection and continue for 48 hours
I experienced COVID-19 after my vaccine in April 2022. I tested for COVID-19 on 03/14/2023. I had nasal congestion and contacted my doctor and I received PAXLOVID. I took the PAXLOVID for five days. I also had fatigue and I also had symptoms form the PAXLOVID. I have recovered from my COVID-19 symptoms.
The morning of January 27, 2023, I woke up with a scratchy throat. I tested negative for COVID-19. I tested negative for COVID-19 again on January 30, 2023, but I wasn't feeling better. I called my doctor to schedule an appointment. I also had runny nose, loss of appetite, and a cough. He diagnosed me with an unspecified upper respiratory illness. I wasn't feeling any better by February 03, 2023. I scheduled another doctor's appointment. My throat had cobble stoning, but my lungs were clear. He diagnosed Sinusitis. He prescribed doxycycline. I had fatigue for about three weeks.
With the 1st vaccine I had a headache and was lethargic.  With the 2nd vaccine I had a headache for 2 days; a scratchy sore throat for 1.5 days and a high fever for 3 or so days. Total symptoms lasted about 4 days
This spontaneous report as received from a medical assistant, refers to a patient of unknown age and gender. No pertinent medical history, drug reactions/allergies or concurrent conditions were reported. On an unknown date, the patient was vaccinated with an improperly stored VAQTA (which had a lot # of R003739 and an expiration date of 16-MAR-2019; however, dose, dosage number and route of administration were not reported), for prophylaxis. Nonetheless, no adverse effects were reported. The vaccine experienced the following temperature excursion on an unknown date: below 32F°/0°C (-1.2C) for 21 hours. Reportedly, there had been no previous temperature excursions and the aforementioned one was identified due to a data logger. Furthermore, no product quality complaint was involved. Sender's Comments: US-009507513-1807USA006219: US-009507513-1807USA006220: US-009507513-1807USA006221: US-009507513-1807USA006217: US-009507513-1807USA000939.
Passed out and injured chin on night of vaccine, woke in a sweat, had a fever. arm swollen and hot and red at site. Fell on cement 2 days later bruising both knees, now neck and back pain.  Feeling woozy 7 days later (possibly due to concusssion).
pt vax while preg; LMP was on 8/17/98; preg confirmed by HCG test; EDD 5/24/99; pt exp spontaneous abortion on 10/14/98;
Patient received shot in left deltoid on 10/6/09. On 10/20/09, she came to health unit & complained of this arm hurting her when she used/ moved it. RN inspected arm & saw no abnormalities (swelling, redness, tender to touch). Advised to report to appropriate numbers and to see PMD. 10/28/09 she said arm still hurts from elbow to shoulder at time saw PMD.
Headache, Myalgia, fatigue Narrative:  pronounced headache on day of shot with fatigue and pretty righteous arm pain that has led to shoulder and neck pain on the side the shot was administered to.
19Dec2021 - arm pain and chest tightness 20Dec2021 - arm pain, chest pain, chest numbness, icy feeling on chest, chills, body ache, fatigue 21Dec2021 - chest pain when stressed mostly, chest numbness 22Dec2022 - chest tightness now shifting from right to left (prior to now was only on left side)
Moderna Booster requires a half dose, 0.25mL. A full dose, 0.5mL was inadvertently administered. No reaction was noted. Client reported no adverse reactions 2 days post vaccination as well.
Myocarditis s/p 2nd COVID shot. Presented with chest pain, elevated troponin with ST elevations in multiple leads. Normal Echocardiogram. Treated with Methylprednisolone and Toradol. Downtrending troponin with clinical improvement at time of report. Currently still hospitalized in PICU during the time report was made.
Information has been received from a nurse practitioner concerning a 19 year old (initially reported as a 17 year old) black female who on 2/12/03 was vaccinated with a second dose of MMR (second generation) (lot # 642700/0528) five weeks after her last menstrual period (approximately 1/8/03). The patient then found out that she was already pregnant at the time of vaccination. In approximately March 2003 a urine beta-human chorionic gonadoptropin test confirmed the pregnancy. The patient had no previous pregnancies. It was reported that no diagnostic testing was done during pregnancy and the patient had no reported illnesses or infections during pregnancy. It was reported that the patient took no prescription drugs during pregnancy. In March 200 the pregnancy ended in a spontaneous abortion 9 weeks after the last menstrual period. Unspecified medical attention was sought for the vaccine exposure during pregnancy, but it is unknown if medical attention was sought for the spontaneous abortion. No further information is expected.